The recent role of lipoprotein(a) in cardiovascular diseases and premature acute coronary syndromes (RELACS) study found that elevated Lp(a) is linked to earlier onset and greater complexity of CAD in ACS patients, emphasizing the need for targeted management strategies in individuals with high Lp(a), particularly in primary prevention [14]. This evidence concerns the gene LPA and acute coronary syndrome.